First national health research agenda in Malawi

Published on 24 February 2012 in 'Announcements'

The first Malawi National Health Research Agenda (NHRA) will be presented in Lilongwe, Malawi, today Friday 24 February 2012. The NHRA describes the national priorities for the research efforts of Malawi for the next five years in order to inform pol...

Read more »

SASHA project preparing for adolescent HIV vaccine trials in South Africa completed

Published on 24 February 2012 in 'Press Releases'

The EDCTP-funded SASHA project has successfully completed a study of the possibilities for conducting HIV vaccine prevention trials in South Africa with adolescents, a group which has a particularly high-risk for HIV infection. By using the HPV vacc...

Read more »

‘PanACEA: a new approach to tuberculosis research’ in The Lancet Infectious Diseases

Published on 23 February 2012 in 'Announcements'

The Lancet infectious Diseases published a news article on the EDCTP-funded PanACEA consortium and its new approach to tuberculosis treatment research. The article is online and will appear in the March 2012 issue. The article is based on interviews ...

Read more »

EDCTP photo contest extended

Published on 9 February 2012 in 'Announcements'

EDCTP has extended the deadline for its First EDCTP photo contest and invites all those working or collaborating in EDCTP-funded projects to enter photographs. The closing date for entry is 16 April 2012.

Read more »

Malaria in pregnancy preventive treatment trial completes recruitment of women

Published on 3 February 2012 in 'Press Releases'

A major milestone in the Malaria in Pregnancy (MiP) field was reached as one of the EDCTP-funded MiP studies completed recruitment. By January 2012, the study had enrolled a total of 4,734 pregnant women in January 2012, after screening 17,947 women ...

Read more »

REMox TB treatment trial completes enrolment

Published on 1 February 2012 in 'Press Releases'

TB Alliance announced today that the enrolment of volunteers in the global REMox TB clinical trial has been completed in January 2012. This is a momentous step forward in the study which aims to establish the efficacy of a possible new drug against t...

Read more »

NIAID expands TB vaccine candidate AERAS-402/Crucell Ad35 clinical trial

Published on 1 February 2012 in 'Announcements'

The National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH) joins the TB vaccine candidate AERAS-402/Crucell Ad35 clinical trial as a partner. Following a new policy NIH is leveragi...

Read more »

EU Commissioner Máire Geoghegan-Quinn discussed EDCTP with Bill Gates

Published on 25 January 2012 in 'Press Releases'

Poverty-related diseases and the European and Developing Countries Clinical Trials Partnership were discussed by Máire Geoghegan-Quinn, EU Commissioner for Research, Innovation and Science, with Mr Bill Gates, Co-Chair of the Bill & Melinda Gates Fou...

Read more »

TBVI Symposium: Europe and ACP together against tuberculosis

Published on 25 January 2012 in 'Announcements'

On the occasion of the World Tuberculosis Day on 22 March 2012, the Tuberculosis Vaccine Initiative (TBVI) will hold the symposium ‘Europe and ACP together against tuberculosis’ in Brussels. Under the patronage of MEP Charles Goerens, and co-hosted b...

Read more »

Simplified artesunate regimen found efficacious in treating children with severe malaria

Published on 20 December 2011 in 'Announcements'

A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard longer regimen. The EDCTP-funded SMAC phase II studies, coordinated by Prof. Peter G. Kremsner, have shown that three doses over two days of the drug ...

Read more »